Hideyuki Shimizu

J-GLOBAL         Last updated: Sep 6, 2019 at 19:04
 
Avatar
Name
Hideyuki Shimizu
Affiliation
Kyushu University
Section
Medical Institute of Bioregulation
Research funding number
70826263

Research Areas

 
 

Academic & Professional Experience

 
Apr 2018
 - 
Today
九州大学
 

Education

 
Apr 2006
 - 
Mar 2012
School of Medicine, Tohoku University
 

Published Papers

 
Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis
Yoshiharu Muto, Toshiro Moroishi, Kazuya Ichihara, Masaaki Nishiyama, Hideyuki Shimizu, Hidetoshi Eguchi, Kyoji Moriya, Kazuhiko Koike, Koshi Mimori, Masaki Mori, Yuta Katayama, and Keiichi I. Nakayama
J Exp Med   216(4) 950-965   Apr 2019   [Refereed]
Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells
Hideyuki Shimizu, Shoichiro Takeishi, Hirokazu Nakatsumi, and Keiichi I. Nakayama
JCI Insight   4(4) 125138   Feb 2019   [Refereed]
Saiki Y, Yoshino Y, Fujimura H, Manabe T, Kudo Y, Shimada M, Mano N, Nakano T, Lee Y, Shimizu S, Oba S, Fujiwara S, Shimizu H, Chen N, Nezhad ZK, Jin G, Fukushige S, Sunamura M, Ishida M, Motoi F, Egawa S, Unno M, Horii A
Biochemical and biophysical research communications   421(1) 98-104   Apr 2012   [Refereed]
Shimizu H, Horii A, Sunamura M, Motoi F, Egawa S, Unno M, Fukushige S
Biochemical and biophysical research communications   411(1) 162-167   Jul 2011   [Refereed]

Conference Activities & Talks

 
An artificial intelligence-based scoring system precisely predicts overall survival of breast cancer patients
Hideyuki Shimizu
20 Sep 2018   
"Wake-up" approach by Fbxw7 inhibition eradicates dormant, chemotherapy-resistant solid tumor cells
Hideyuki Shimizu
9 Dec 2017   
Development of a novel approach to breast cancer treatment by targeting Fbxw7
Hideyuki Shimizu
30 Nov 2016   
Identification of epigenetically silenced genes by the novel “methyl-CpG targeted transcriptional activation” method in human pancreatic cancer
Hideyuki Shimizu
AACR-JCA 8th Joint Conference   8 Feb 2010